EcoDrugPlus

Ensembl ID : WBGene00224187
Gene Symbol: WBGENE00224187
4 External references
84 Possible Orthologues:

Ensembl ID : WBGene00224191
Gene Symbol: WBGENE00224191
4 External references
98 Possible Orthologues:

Ensembl ID : WBGene00224250
Gene Symbol: WBGENE00224250
4 External references
96 Possible Orthologues:

Ensembl ID : WBGene00224268
Gene Symbol: WBGENE00224268
3 External references
59 Possible Orthologues:

Ensembl ID : WBGene00224290
Gene Symbol: WBGENE00224290
6 External references
558 Possible Orthologues:

Ensembl ID : WBGene00224308
Gene Symbol: WBGENE00224308
6 External references
255 Possible Orthologues:

Ensembl ID : WBGene00224390
Gene Symbol: WBGENE00224390
4 External references
60 Possible Orthologues:

Ensembl ID : WBGene00224409
Gene Symbol: WBGENE00224409
6 External references
183 Possible Orthologues:

Ensembl ID : WBGene00224413
Gene Symbol: WBGENE00224413
4 External references
59 Possible Orthologues:

Ensembl ID : WBGene00224440
Gene Symbol: WBGENE00224440
4 External references
882 Possible Orthologues:

Ensembl ID : WBGene00224517
Gene Symbol: WBGENE00224517
6 External references
133 Possible Orthologues:

Ensembl ID : WBGene00220320
Gene Symbol: WBGENE00220320
3 External references
1193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).